Tourette Syndrome Drug Market
1 Study Coverage
1.1 Tourette Syndrome Drug Product Introduction
1.2 Market by Type
1.2.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tourette Syndrome Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Tourette Syndrome Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Tourette Syndrome Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tourette Syndrome Drug Sales by Region
2.4.1 Global Tourette Syndrome Drug Sales by Region (2017-2022)
2.4.2 Global Sales Tourette Syndrome Drug by Region (2023-2028)
2.5 Global Tourette Syndrome Drug Revenue by Region
2.5.1 Global Tourette Syndrome Drug Revenue by Region (2017-2022)
2.5.2 Global Tourette Syndrome Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tourette Syndrome Drug Sales by Manufacturers
3.1.1 Global Top Tourette Syndrome Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tourette Syndrome Drug in 2021
3.2 Global Tourette Syndrome Drug Revenue by Manufacturers
3.2.1 Global Tourette Syndrome Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2021
3.3 Global Tourette Syndrome Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tourette Syndrome Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tourette Syndrome Drug Sales by Type
4.1.1 Global Tourette Syndrome Drug Historical Sales by Type (2017-2022)
4.1.2 Global Tourette Syndrome Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
4.2 Global Tourette Syndrome Drug Revenue by Type
4.2.1 Global Tourette Syndrome Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Tourette Syndrome Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
4.3 Global Tourette Syndrome Drug Price by Type
4.3.1 Global Tourette Syndrome Drug Price by Type (2017-2022)
4.3.2 Global Tourette Syndrome Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tourette Syndrome Drug Sales by Application
5.1.1 Global Tourette Syndrome Drug Historical Sales by Application (2017-2022)
5.1.2 Global Tourette Syndrome Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
5.2 Global Tourette Syndrome Drug Revenue by Application
5.2.1 Global Tourette Syndrome Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Tourette Syndrome Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
5.3 Global Tourette Syndrome Drug Price by Application
5.3.1 Global Tourette Syndrome Drug Price by Application (2017-2022)
5.3.2 Global Tourette Syndrome Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tourette Syndrome Drug Market Size by Type
6.1.1 North America Tourette Syndrome Drug Sales by Type (2017-2028)
6.1.2 North America Tourette Syndrome Drug Revenue by Type (2017-2028)
6.2 North America Tourette Syndrome Drug Market Size by Application
6.2.1 North America Tourette Syndrome Drug Sales by Application (2017-2028)
6.2.2 North America Tourette Syndrome Drug Revenue by Application (2017-2028)
6.3 North America Tourette Syndrome Drug Market Size by Country
6.3.1 North America Tourette Syndrome Drug Sales by Country (2017-2028)
6.3.2 North America Tourette Syndrome Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Tourette Syndrome Drug Market Size by Type
7.1.1 Europe Tourette Syndrome Drug Sales by Type (2017-2028)
7.1.2 Europe Tourette Syndrome Drug Revenue by Type (2017-2028)
7.2 Europe Tourette Syndrome Drug Market Size by Application
7.2.1 Europe Tourette Syndrome Drug Sales by Application (2017-2028)
7.2.2 Europe Tourette Syndrome Drug Revenue by Application (2017-2028)
7.3 Europe Tourette Syndrome Drug Market Size by Country
7.3.1 Europe Tourette Syndrome Drug Sales by Country (2017-2028)
7.3.2 Europe Tourette Syndrome Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tourette Syndrome Drug Market Size by Type
8.1.1 Asia Pacific Tourette Syndrome Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Tourette Syndrome Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Tourette Syndrome Drug Market Size by Application
8.2.1 Asia Pacific Tourette Syndrome Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Tourette Syndrome Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Tourette Syndrome Drug Market Size by Region
8.3.1 Asia Pacific Tourette Syndrome Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Tourette Syndrome Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Tourette Syndrome Drug Market Size by Type
9.1.1 Latin America Tourette Syndrome Drug Sales by Type (2017-2028)
9.1.2 Latin America Tourette Syndrome Drug Revenue by Type (2017-2028)
9.2 Latin America Tourette Syndrome Drug Market Size by Application
9.2.1 Latin America Tourette Syndrome Drug Sales by Application (2017-2028)
9.2.2 Latin America Tourette Syndrome Drug Revenue by Application (2017-2028)
9.3 Latin America Tourette Syndrome Drug Market Size by Country
9.3.1 Latin America Tourette Syndrome Drug Sales by Country (2017-2028)
9.3.2 Latin America Tourette Syndrome Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tourette Syndrome Drug Market Size by Type
10.1.1 Middle East and Africa Tourette Syndrome Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tourette Syndrome Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Tourette Syndrome Drug Market Size by Application
10.2.1 Middle East and Africa Tourette Syndrome Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tourette Syndrome Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Tourette Syndrome Drug Market Size by Country
10.3.1 Middle East and Africa Tourette Syndrome Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abide Therapeutics Inc
11.1.1 Abide Therapeutics Inc Corporation Information
11.1.2 Abide Therapeutics Inc Overview
11.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abide Therapeutics Inc Recent Developments
11.2 Catalyst Pharmaceuticals Inc
11.2.1 Catalyst Pharmaceuticals Inc Corporation Information
11.2.2 Catalyst Pharmaceuticals Inc Overview
11.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Catalyst Pharmaceuticals Inc Recent Developments
11.3 Neurocrine Biosciences Inc
11.3.1 Neurocrine Biosciences Inc Corporation Information
11.3.2 Neurocrine Biosciences Inc Overview
11.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Neurocrine Biosciences Inc Recent Developments
11.4 Psyadon Pharmaceuticals Inc
11.4.1 Psyadon Pharmaceuticals Inc Corporation Information
11.4.2 Psyadon Pharmaceuticals Inc Overview
11.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Psyadon Pharmaceuticals Inc Recent Developments
11.5 Reviva Pharmaceuticals Inc
11.5.1 Reviva Pharmaceuticals Inc Corporation Information
11.5.2 Reviva Pharmaceuticals Inc Overview
11.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Reviva Pharmaceuticals Inc Recent Developments
11.6 Synchroneuron Inc
11.6.1 Synchroneuron Inc Corporation Information
11.6.2 Synchroneuron Inc Overview
11.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Synchroneuron Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Synchroneuron Inc Recent Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.7.2 Teva Pharmaceutical Industries Ltd Overview
11.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.8 Therapix Biosciences Ltd
11.8.1 Therapix Biosciences Ltd Corporation Information
11.8.2 Therapix Biosciences Ltd Overview
11.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Therapix Biosciences Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tourette Syndrome Drug Industry Chain Analysis
12.2 Tourette Syndrome Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tourette Syndrome Drug Production Mode & Process
12.4 Tourette Syndrome Drug Sales and Marketing
12.4.1 Tourette Syndrome Drug Sales Channels
12.4.2 Tourette Syndrome Drug Distributors
12.5 Tourette Syndrome Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tourette Syndrome Drug Industry Trends
13.2 Tourette Syndrome Drug Market Drivers
13.3 Tourette Syndrome Drug Market Challenges
13.4 Tourette Syndrome Drug Market Restraints
14 Key Findings in The Global Tourette Syndrome Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Tourette Syndrome Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of AZD-5213
Table 3. Major Manufacturers of CPP-115
Table 4. Major Manufacturers of Dutetrabenazine ER
Table 5. Major Manufacturers of Ecopipam Hydrochloride
Table 6. Major Manufacturers of Others
Table 7. Global Tourette Syndrome Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Tourette Syndrome Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Tourette Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Tourette Syndrome Drug Sales Market Share by Region (2017-2022)
Table 11. Global Tourette Syndrome Drug Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Tourette Syndrome Drug Sales Market Share by Region (2023-2028)
Table 13. Global Tourette Syndrome Drug Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Tourette Syndrome Drug Revenue Market Share by Region (2017-2022)
Table 15. Global Tourette Syndrome Drug Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Tourette Syndrome Drug Revenue Market Share by Region (2023-2028)
Table 17. Global Tourette Syndrome Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Tourette Syndrome Drug Sales Share by Manufacturers (2017-2022)
Table 19. Global Tourette Syndrome Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Tourette Syndrome Drug Revenue Share by Manufacturers (2017-2022)
Table 21. Tourette Syndrome Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Tourette Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Drug as of 2021)
Table 24. Tourette Syndrome Drug Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Tourette Syndrome Drug Product Offered
Table 26. Date of Manufacturers Enter into Tourette Syndrome Drug Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Tourette Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Tourette Syndrome Drug Sales Share by Type (2017-2022)
Table 31. Global Tourette Syndrome Drug Sales Share by Type (2023-2028)
Table 32. Global Tourette Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Tourette Syndrome Drug Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Tourette Syndrome Drug Revenue Share by Type (2017-2022)
Table 35. Global Tourette Syndrome Drug Revenue Share by Type (2023-2028)
Table 36. Tourette Syndrome Drug Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Tourette Syndrome Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Tourette Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Tourette Syndrome Drug Sales Share by Application (2017-2022)
Table 41. Global Tourette Syndrome Drug Sales Share by Application (2023-2028)
Table 42. Global Tourette Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Tourette Syndrome Drug Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Tourette Syndrome Drug Revenue Share by Application (2017-2022)
Table 45. Global Tourette Syndrome Drug Revenue Share by Application (2023-2028)
Table 46. Tourette Syndrome Drug Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Tourette Syndrome Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Tourette Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Tourette Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Tourette Syndrome Drug Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Tourette Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Tourette Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Tourette Syndrome Drug Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Tourette Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Tourette Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Tourette Syndrome Drug Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Tourette Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Tourette Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Tourette Syndrome Drug Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Tourette Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Tourette Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Tourette Syndrome Drug Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Tourette Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Tourette Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Tourette Syndrome Drug Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Tourette Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Tourette Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Tourette Syndrome Drug Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Tourette Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Tourette Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Tourette Syndrome Drug Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Tourette Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Tourette Syndrome Drug Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Tourette Syndrome Drug Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Tourette Syndrome Drug Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Tourette Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Tourette Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Tourette Syndrome Drug Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Tourette Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Tourette Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Tourette Syndrome Drug Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Tourette Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Tourette Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Tourette Syndrome Drug Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Tourette Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Tourette Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Tourette Syndrome Drug Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Tourette Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Tourette Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Tourette Syndrome Drug Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Tourette Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2023-2028) & (US$ Million)
Table 108. Abide Therapeutics Inc Corporation Information
Table 109. Abide Therapeutics Inc Description and Major Businesses
Table 110. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Abide Therapeutics Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Abide Therapeutics Inc Recent Developments
Table 113. Catalyst Pharmaceuticals Inc Corporation Information
Table 114. Catalyst Pharmaceuticals Inc Description and Major Businesses
Table 115. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Catalyst Pharmaceuticals Inc Recent Developments
Table 118. Neurocrine Biosciences Inc Corporation Information
Table 119. Neurocrine Biosciences Inc Description and Major Businesses
Table 120. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Neurocrine Biosciences Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Neurocrine Biosciences Inc Recent Developments
Table 123. Psyadon Pharmaceuticals Inc Corporation Information
Table 124. Psyadon Pharmaceuticals Inc Description and Major Businesses
Table 125. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Psyadon Pharmaceuticals Inc Recent Developments
Table 128. Reviva Pharmaceuticals Inc Corporation Information
Table 129. Reviva Pharmaceuticals Inc Description and Major Businesses
Table 130. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Reviva Pharmaceuticals Inc Recent Developments
Table 133. Synchroneuron Inc Corporation Information
Table 134. Synchroneuron Inc Description and Major Businesses
Table 135. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Synchroneuron Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Synchroneuron Inc Recent Developments
Table 138. Teva Pharmaceutical Industries Ltd Corporation Information
Table 139. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 140. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Teva Pharmaceutical Industries Ltd Recent Developments
Table 143. Therapix Biosciences Ltd Corporation Information
Table 144. Therapix Biosciences Ltd Description and Major Businesses
Table 145. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 146. Therapix Biosciences Ltd Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Therapix Biosciences Ltd Recent Developments
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Tourette Syndrome Drug Distributors List
Table 151. Tourette Syndrome Drug Customers List
Table 152. Tourette Syndrome Drug Market Trends
Table 153. Tourette Syndrome Drug Market Drivers
Table 154. Tourette Syndrome Drug Market Challenges
Table 155. Tourette Syndrome Drug Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Tourette Syndrome Drug Product Picture
Figure 3. Global Tourette Syndrome Drug Market Share by Type in 2021 & 2028
Figure 3. AZD-5213 Product Picture
Figure 4. CPP-115 Product Picture
Figure 5. Dutetrabenazine ER Product Picture
Figure 6. Ecopipam Hydrochloride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tourette Syndrome Drug Market Share by Application in 2021 & 2028
Figure 9. Research Center
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Tourette Syndrome Drug Report Years Considered
Figure 14. Global Tourette Syndrome Drug Sales 2017-2028 (K Pcs)
Figure 15. Global Tourette Syndrome Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Tourette Syndrome Drug Revenue 2017-2028 (US$ Million)
Figure 17. Global Tourette Syndrome Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Tourette Syndrome Drug Sales Market Share by Region (2017-2022)
Figure 19. Global Tourette Syndrome Drug Sales Market Share by Region (2023-2028)
Figure 20. North America Tourette Syndrome Drug Sales YoY (2017-2028) & (K Pcs)
Figure 21. North America Tourette Syndrome Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Tourette Syndrome Drug Sales YoY (2017-2028) & (K Pcs)
Figure 23. Europe Tourette Syndrome Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Tourette Syndrome Drug Sales YoY (2017-2028) & (K Pcs)
Figure 25. Asia-Pacific Tourette Syndrome Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Tourette Syndrome Drug Sales YoY (2017-2028) & (K Pcs)
Figure 27. Latin America Tourette Syndrome Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Tourette Syndrome Drug Sales YoY (2017-2028) & (K Pcs)
Figure 29. Middle East & Africa Tourette Syndrome Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Tourette Syndrome Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Tourette Syndrome Drug in the World: Market Share by Tourette Syndrome Drug Revenue in 2021
Figure 32. Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 37. North America Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 39. North America Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 41. North America Tourette Syndrome Drug Sales Share by Country (2017-2028)
Figure 42. North America Tourette Syndrome Drug Revenue Share by Country (2017-2028)
Figure 43. U.S. Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 47. Europe Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 49. Europe Tourette Syndrome Drug Sales Share by Country (2017-2028)
Figure 50. Europe Tourette Syndrome Drug Revenue Share by Country (2017-2028)
Figure 51. Germany Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 52. France Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Tourette Syndrome Drug Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Tourette Syndrome Drug Revenue Share by Region (2017-2028)
Figure 62. China Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 65. India Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 73. Latin America Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 75. Latin America Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Tourette Syndrome Drug Sales Share by Country (2017-2028)
Figure 77. Latin America Tourette Syndrome Drug Revenue Share by Country (2017-2028)
Figure 78. Mexico Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Tourette Syndrome Drug Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Tourette Syndrome Drug Revenue Share by Country (2017-2028)
Figure 87. Turkey Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Tourette Syndrome Drug Revenue (2017-2028) & (US$ Million)
Figure 90. Tourette Syndrome Drug Value Chain
Figure 91. Tourette Syndrome Drug Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
Industry Market Size
